Share This Article:

Status of ESBL Producing Bacteria Isolated from Skin Wound at a Tertiary Care Hospital in Bangladesh

Abstract Full-Text HTML XML Download Download as PDF (Size:377KB) PP. 174-179
DOI: 10.4236/aid.2015.54022    3,675 Downloads   4,299 Views   Citations

ABSTRACT

Background: ESBL producing bacteria are increasing with an alarming rate with a wide range of infections. Objective: The purpose of the present study was to see the status of ESBL producing bacteria isolated from skin wounds. Methodology: This cross sectional study was conducted in the Department of Microbiology at Mymensingh Medical College, Bangladesh from January 2011 to June 2011 for a period of 6 months. All the patients, at any age with both sexes presented with skin wound infection, were taken as study population. Wound swab was taken from all patients. Specimens were processed and bacteria were isolated and identified according to standard procedure. The ESBL status was confirmed by double disc diffusion test (DDDT) and minimum inhibitory concentration (MIC) by agar dilution method by standard procedure according to Clinical Laboratory Standard Institute (CLSI). Antimicrobial resistance was done by disc diffusion method. Result: A total number of 84 wound swabs were taken of which the most common ESBL producing bacteria were Esch. coli (61.5%), Proteus species (78.3%) and Klebsiella species (88.9%). All the isolates were sensitive to imipenem and nitrofurantoin followed by amikacin (92.9%). Conclusion: In conclusion, ESBL producing E. coli is the most common bacteria causing skin wound infection followed by Proteus species with a reduced sensitivity towards antibiotics.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Yasmin, T. , Yusuf, M. , Sayam, M. , Haque, R. and Mowla, G. (2015) Status of ESBL Producing Bacteria Isolated from Skin Wound at a Tertiary Care Hospital in Bangladesh. Advances in Infectious Diseases, 5, 174-179. doi: 10.4236/aid.2015.54022.

References

[1] DiNubile, M.J. and Lipsky, B.A. (2004) Complicated Infections of Skin and Skin Structures: When the Infection Is More than Skin Deep. Journal of Antimicrobial Chemotherapy, 53, ii37-ii50.
http://dx.doi.org/10.1093/jac/dkh202
[2] Shahcheraghi, F., Nasiri, S. and Noveiri, H. (2009) Detection of Extended-Spectrum ?2-Lactamases (ESBLs). Archives of Clinical Infectious Diseases, 4, 65-70.
[3] Chaudhary, U. and Aggarwal, R. (2004) Extended Spectrum Beta Lactamases (ESBL)—An Emerging Threat to Clinical Therapeutics. Indian Journal of Medical Microbiology, 22, 75-80.
[4] Paterson, D.L. and Bonomo, R.A. (2005) Extended-Spectrum Beta-Lactamases: A Clinical Update. Clinical Microbiology Reviews, 18, 657-686. http://dx.doi.org/10.1128/CMR.18.4.657-686.2005
[5] Perez, F., Endimiani, A., Hujer, K.M. and Bonomo, R.A. (2007) The Continuing Challenge of ESBLs. Current Opinion in Pharmacology, 7, 459-469. http://dx.doi.org/10.1016/j.coph.2007.08.003
[6] Andrews, J. (2012) British Society for Antimicrobial Chemotherapy (BSAC) Detection of Extended-Spectrum β-Lactamases (ESBLs) in E. coli and Klebsiella Species.
http://bsac.org.uk/wp-content/uploads/2012/02/Ecoliklebsiella.pdf
[7] Friedman, C., Callery, S., Jeanes, A., Piaskowski, P. and Scott, L. (2005) Best Infection Control Practices for Patients with Extended Spectrum Beta Lactamase Enterobacteriacae. International Infection Control Council.
[8] Pitout, J.D.D. and Laupland, K.B. (2008) Extended Spectrum β Lactamase Producing Enterobacteriaceae: An Emerging Public Health Concern. Lancet Infectious Diseases, 8, 159-166.
http://dx.doi.org/10.1016/S1473-3099(08)70041-0
[9] Shivaprakasha, S., Radhakrishnan, K., Gireesh, A.R. and Shamsul Karim, P.M. (2007) Routine Screening for ESBL Production. A Necessity of Today. Internet Journal of Microbiology, 3.
[10] Sasirekha, B., Manasa, R., Ramya, P. and Sneha, R. (2010) Frequency and Antimicrobial Sensitivity Pattern of Extended Spectrum β-Lactamases Producing Esch. coli and Klebsiella pneumoniae Isolated in a Tertiary Care Hospital. Al Ameen Journal of Medical Science, 3, 265-271.
[11] Shobha, K.L., Gowrish, R.S., Sugandhi, R. and Sreeja, C.K. (2007) Prevalence of Extended Spectrum β Lactamases in Urinary Isolates of Escherichia coli, Klebsiella and Citrobacter Species and Their Antimicrobial Susceptibility Pattern in Tertiary Care Hospital. Indian Journal for the Practising Doctor, 3, 1-2.
[12] Agrawal, P., Ghosh, A., Kumar, S., Basu, B. and Kapil, K. (2008) Prevalence of Extended Spectrum β Lactamases among E. coli and K. pneumoniae Isolates in Tertiary Care Hospital. Indian Journal of Pathology and Microbiology, 51, 139-142. http://dx.doi.org/10.4103/0377-4929.40428
[13] Yushau, M., Aliyu, H.M., Kumurya, A.S. and Suleiman, K. (2010) Prevalence of Extended Spectrum β Lactamases among Enterobacteriaceae in Murtala Mohammed Specialist Hospital, Kano, Nigeria. Bayero Journal of Pure and Applied Sciences, 3, 169-172.
[14] Hawkey, P.M. (2008) Prevalence and Clonality of Extended-Spectrum β-Lactamases in Asia. Clinical Microbiology and Infection, 14, 159-165. http://dx.doi.org/10.1111/j.1469-0691.2007.01855.x
[15] Rahman, M.M., Haque, J.A., Hossain, M.A., Sultana, R. and Islam, F. (2004) Prevalence of Extended Spectrum Beta Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in an Urban Hospital in Dhaka Bangladesh. International Journal of Antimicrobial Agents, 24, 508-510.
http://dx.doi.org/10.1016/j.ijantimicag.2004.05.007
[16] Cheessbrough, M. (2006) District Laboratory Practice in Tropical Countries. Microbiology-2, Cambridge University Press, New York, 184-186.
[17] Clinical Laboratory Standards Institute (2010) Performance Standards for Antimicrobial Disc Susceptibility Testing. 14th Informational Supplement.
[18] Clinical Laboratory Standards Institute (2006) Performance Standards for Antimicrobial Susceptibility Testing. 16th Informational Supplement, M100-S15.
[19] National Committee for Clinical Laboratory Standards (2003) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, M7-A6.
[20] Haque, N., Hossain, M.A., Bilkis, L., Musa, A.K., Mahamud, C., Bari, M.S., et al. (2009) Antibiotic Susceptibility Pattern of Staphylococcus epidermidis. Mymensingh Medical Journal, 18, 142-147.
[21] Haque, R. and Salam, M.A. (2010) Detection of ESBL Producing Nosocomial Gram Negative Bacteria from a Tertiary Care Hospital in Bangladesh. Pakistan Journal of Medical Sciences, 26, 887-891.
[22] Jabeen, K., Zafar, A., Hasan, R., et al. (2005) Frequency and Sensitivity Pattern of Extended Spectrum Beta Lactamase Producing Isolates in a Tertiary Care Hospital Laboratory of Pakistan. Journal of Pakistan Medical Association, 55, 436-439.
[23] Ullah, F., Malik, S.A. and Ahmed, J. (2009) Antimicrobial Susceptibility Pattern and ESBL Prevalence in Klebsiella pneumoniae from Urinary Tract Infections in the North-West of Pakistan. African Journal of Microbiology Research, 3, 670-680.
[24] Ali, A.M. (2009) Frequency of Extended Spectrum Beta Lactamase (ESBL) Producing Nosocomial Isolates in a Tertiary Care Hospital in Rawalpindi. Journal of the Royal Army Medical Corps, 3, 105-109.
[25] Babypadmini, S. and Appalaraju, B. (2004) Extended Spectrum Beta Lactamases in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae-Prevalence and Susceptibility Pattern in a Tertiary Care Hospital. Indian Journal of Medical Microbiology, 22, 172-174.
[26] Sharma, S., Bhat, G.K. and Shenoy, S. (2007) Virulence Factors and Drug Resistance in Escherichia coli Isolated from Extra Intestinal Infections. Indian Journal of Medical Microbiology, 25, 369-373. http://dx.doi.org/10.4103/0255-0857.37341
[27] Naehi, L., Shahcheraghi, F., Nikbin, V.S. and Nematzadeh, S. (2010) PER, CTX-M, TEM and SHV Beta Lactamases in Clinical Isolates of Klebsiella pneumoniae Isolated from Tehran, Iran. Iranian Journal of Basic Medical Sciences, 13, 111-118.
[28] Lal, P., Kapil, A., Das, B.K. and Sood, S. (2007) Occurrence of TEM and SHV Gene in Extended Spectrum Beta Lactamases (ESBLs) Producing Klebsiella spp. Isolated from a Tertiary Care Hospital. Indian Journal of Medical Research, 125, 173-178.
[29] Sharma, J., Sharma, M. and Roy, P. (2010) Detection of TEM and SHV Genes in Escherichia coli and Klebsiella pneumoniae Isolates in a Tertiary Care Hospital from India. Indian Journal of Medical Microbiology, 132, 332-336.
[30] Tenover, F.C., Mohammed, M.J., Gorton, T.S. and Dembek, Z.F. (1999) Detection and Reporting of Organisms Producing Extended Spectrum Beta-Lactamases: Survey of Laboratories in Connecticut. Journal of Clinical Microbiology, 37, 4065-4070.
[31] Paterson, D.L. and Yu, V.L. (1999) Extended Spectrum Beta Lactamases: A Call for Improved Detection and Control. Clinical Infectious Diseases, 29, 1419-1422. http://dx.doi.org/10.1086/313559
[32] Asna, S.M.Z. and Haq, J.A. (2000) Decrease of Antibiotic Resistance in Salmonella typhi Isolated from Patients Attending Hospitals of Dhaka City over a 3 Year Period. International Journal of Antimicrobial Agents, 16, 249-251. http://dx.doi.org/10.1016/S0924-8579(00)00230-2
[33] Paterson, D.L., Ko, W.C., Gottberg, V., Mohapatra, S., Casellas, J.M., Goossens, H., et al. (2004) Antibiotic Therapy for Klebsiella pneumoniae Bacteriamia: Implications of Production of Extended-Spectrum β-Lactamases. Antibiotics for ESBL Producers CID, 39, 31-37.
[34] Singh, N.P. and Goyal, R. (2003) Changing Trends in Bacteriology of Burns in the Burns Unit, Delhi, India. Burns, 29, 129-132. http://dx.doi.org/10.1016/S0305-4179(02)00249-8
[35] Gonzalez, L.S. and Spencer, J.P. (1998) Aminoglycosides: A Practical Review. American Family Physician, 58, 1811-1820.
[36] Miller, G.H. and Sabatelli, F.J. (1997) The Most Frequent Aminoglycoside Resistance Mechanisms—Changes with Time and Geographic Area: Areflection of Aminoglycoside Usage Patterns? Aminoglycoside Resistance Study Groups. Clinical Infectious Diseases, 24, 46-62.
http://dx.doi.org/10.1093/clinids/24.Supplement_1.S46
[37] Rashid, A., Chowdhury, A., Rahman, S.H., Begum, S.A. and Muazzam, N. (2007) Infections by Pseudomonas aeruginosa and Antibiotic Resistance Pattern of the Isolates from Dhaka Medical College Hospital. Bangladesh Journal of Medical Microbiology, 1, 48-51.
[38] Rhee, Y.J., Park, Y.K., Lee, M.Y., Peck, K.R. and Soo, K.K. (2010) KPC-Producing Extreme Drug-Resistant Klebsiella pneumoniae Isolated from a Patient with Diabetes Mallitus and Chronic Renal Failure on Haemodialysis in South Korea. Antimicrobial Agents and Chemotherapy, 54, 2278-2279.
http://dx.doi.org/10.1128/AAC.00011-10
[39] Amaya, E., Caceres, M., Fang, H., Ramirez, A.T., Palmgren, A.C., Nord, C.E. and Weintraub, A. (2009) Extended Spectrum Beta Lactamase-Producing Klebsiella pneumoniae in a Neonatal Intensive Care Unit in Leon, Nicaragua. International Journal of Antimicrobial Agents, 33, 386-387.
http://dx.doi.org/10.1016/j.ijantimicag.2008.10.004

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.